Insights On Solid Dose Manufacturing

31. NanoImprove The Performance Of Your Formulations 9/24/2024

    Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

32. Intro To USP <1062> - What It Is And Why You Should Use It 7/20/2023

    Knowing how to use USP <1062> helps manufacturers manage the wide variety of factors that can exacerbate production costs, or result in no product at all.

33. Optimizing Tablets For Even Splitting: The Pressure Sensitive Bisect Design 11/11/2024

    The pressure-sensitive bisect design allows accurate tablet splitting by maximizing facet width, optimizing angles, and balancing radius values for durability and user-friendly administration.

34. 4 Key Factors To Consider During The Design Process In Aseptic Manufacturing 3/27/2025

    From de-risking initial processes to planning full-scale production, crucial decisions shape success. Explore four vital factors that demand careful consideration during the design phase.

35. Fundamentals Of Power Blending Simulations 2/26/2025

    Predicting blending quality doesn't have to be a guessing game. Learn how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.

36. Combining Patient Centricity And Commercial Viability In Pediatric Product Development 8/15/2024

    Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.

37. Head Pressure In Your Hopper: What Is It, And How Do You Mitigate It? 7/30/2024

    What is head pressure in your hopper and how does it relate to tablet press performance?

38. A Micronization Method Enabling The Formulation Of Biopharmaceuticals 6/29/2023

    See how applying lyophilization-based micronization methodology at a small scale helps to support challenging formulation development projects.

39. Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission 6/26/2024

    The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.

40. Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives 7/17/2024

    A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.